Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'S TOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
RubyWell is an intelligent and automated guide that helps family caregivers regain financial stability by continuously discovering and delivering new savings, benefits, and compensation opportunities.
AstroMind
Seed Round in 2024
AstroMind is a technology company.
Citizen Health
Seed Round in 2024
Over 350+ million people worldwide are affected by one of the 10,000+ rare diseases of which 95% do not have a single treatment available. Through our AI-powered platform, we liberate and structure data to radically improve rare and complex disease treatment, widen access to expert care, and revolutionize the development of new medicines at a fraction of the speed previously proven possible. Patients can share their health data across our multi-sided platform with caregivers, providers and researchers to illuminate better treatment and support options, while bringing therapies to patients faster. We support thousands of patients, work with a rapidly growing network of patient advocacy organizations, and innovate with leading biopharma organizations to accelerate therapies, always ensuring patients remain at the center.
AstroMind
Seed Round in 2024
AstroMind is a technology company.
Esperto Medical
Series A in 2024
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostics for both hospital and remote patient monitoring. The company utilizes innovative resonance sonomanometry technology, which employs acoustic stimulation to provide continuous and noninvasive blood pressure measurements without the need for calibration. By enabling round-the-clock monitoring of vital signs, Esperto Medical’s devices aim to enhance accessibility to medical care through automation, allowing patients to effectively manage their health from home or within clinical settings.
FreeNav
Seed Round in 2024
Founded in 2021 to provide a better solution to the need for more effective tracking of clinical tools and instruments during minimally invasive procedures. As medical procedures utilize smaller incisions, demand for better visualization and navigation is increasing. FreeNav’s wireless EM solutions provide instrument manufacturers state-of-the-art technology to equip clinical users with trackable tools. FreeNav is based in the Twin Cities of Minneapolis-St. Paul, and ideally positioned to draw from its thriving Life Sciences and Medical Devices ecosystem and the robust local investment community.
Feeling Great
Seed Round in 2024
Feeling Great app quickly reduces negative feelings, boosts joy and self-esteem and blows your mind.
Selfii
Seed Round in 2024
Selfii is a healthcare data collection platform used to support monetization of patient-consented data. Its platform helps individuals and organizations harness the full potential of their health records. It collects healthcare data from diverse sources, including electronic health records (EHRs) and patient-generated data, to allow patients access a comprehensive view of their health records in one place.
Marigold Health
Series A in 2024
Marigold Health operates a social network community platform that provides AI-augmented chat support groups designed to assist individuals with behavioral health needs. By facilitating anonymous text-based group therapies, the company enables patients dealing with mental health and substance use conditions to connect and support one another. These support groups are complemented by the involvement of recovery coaches who help participants formulate personalized recovery plans. Marigold Health partners with treatment providers and managed care organizations within the Medicaid market, aiming to enhance patient engagement while allowing care teams to manage increased capacity effectively. Through its innovative approach, the company offers on-demand, stigma-free support for individuals seeking to improve their mental health.
Materna Medical
Venture Round in 2024
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce maternal childbirth-related injuries during vaginal delivery. Established in 2010, the company addresses significant unmet needs in women's pelvic health, positioning itself within a $6 billion market. Materna Medical aims to transform the standard of care in obstetrics and gynecology by leveraging advanced technologies and a diverse team of engineers, scientists, and commercial leaders. The company’s mission is to empower women to safeguard their pelvic health through its novel medical devices.
Elektra Health
Seed Round in 2024
Elektra Health is a digital healthcare platform designed to support women navigating perimenopause and menopause, addressing the significant disruptions these life stages can cause. With a focus on education and community, Elektra aims to eliminate the stigma surrounding hormonal changes and menopause. The platform offers access to telemedicine services provided by board-certified clinicians, along with an evidence-based educational program and a private community for women. By providing these resources, Elektra empowers women to take control of their health and well-being during this critical phase of life, as many women currently face inadequate care despite experiencing challenging symptoms such as anxiety, depression, and joint pain.
Nest Collaborative
Series A in 2024
Nest Collaborative is a healthcare company that focuses on providing comprehensive lactation support through its online platform. It connects parents and parents-to-be with board-certified lactation consultants who offer virtual counseling services year-round. The company's approach emphasizes preventive care, aiming to improve access to lactation support and reduce associated costs. By employing evidence-based interventions, Nest Collaborative addresses the unique challenges many families face when breastfeeding, including physiological, emotional, societal, and economic barriers. Its services encompass breastfeeding education, prenatal planning, and practical tips for balancing motherhood, allowing mothers to access consultations without the need for co-pays. Through these offerings, Nest Collaborative seeks to extend the duration of breastfeeding and enhance the overall experience for families.
Ciitizen
Seed Round in 2023
Ciitizen Corporation is a healthcare technology company based in Palo Alto, California, that operates a digital platform designed to empower patients to collect, organize, and share their personal health information, including genomic data and lab results. Founded in 2017, Ciitizen aims to give individuals control over their complete health records, facilitating the sharing of this information with caregivers, researchers, and other relevant parties. The platform addresses the limitations of existing health data portals, which often provide only minimal information and rely on labor-intensive processes to extract insights from unstructured data. By normalizing diverse health information into actionable formats, Ciitizen enhances transparency and accessibility for patients and healthcare providers alike. The company is led by CEO Anil Sethi and is supported by a prominent investment team.
Elektra Health
Seed Round in 2023
Elektra Health is a digital healthcare platform designed to support women navigating perimenopause and menopause, addressing the significant disruptions these life stages can cause. With a focus on education and community, Elektra aims to eliminate the stigma surrounding hormonal changes and menopause. The platform offers access to telemedicine services provided by board-certified clinicians, along with an evidence-based educational program and a private community for women. By providing these resources, Elektra empowers women to take control of their health and well-being during this critical phase of life, as many women currently face inadequate care despite experiencing challenging symptoms such as anxiety, depression, and joint pain.
Omniox
Series A in 2023
Omniox is a biopharmaceutical company focused on developing innovative treatments for diseases associated with hypoxia, a condition characterized by inadequate oxygen levels in tissues. This lack of oxygen is linked to various serious health issues, including certain cancers and cardiovascular diseases. The company utilizes its proprietary H-NOX platform technology, which is designed to deliver oxygen and nitric oxide specifically to hypoxic tissues. This targeted approach aims to restore normal tissue function and improve patient outcomes by addressing the underlying causes of hypoxia-related diseases. Through its advancements in biologics, Omniox seeks to provide meaningful therapeutic benefits and enable healthcare professionals to develop effective oxygen-based therapies that enhance patient health and recovery.
Pear Bio
Series A in 2023
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.
32Co
Seed Round in 2023
32Co is a medical technology platform focused on enhancing the capabilities of general dentists in delivering clear aligner orthodontics. The company facilitates a collaborative healthcare environment by connecting general dentists with specialist orthodontists for one-on-one mentorship. Through its platform, 32Co leverages artificial intelligence to provide educational resources that upskill clinicians, thereby empowering them to deliver high-quality dental care and treatments. This approach not only improves patient outcomes but also fosters professional growth among dentists by ensuring they have access to specialized knowledge and expertise.
Gradient Health
Seed Round in 2023
Gradient Health is a developer of an open research platform that specializes in AI-based medical imaging diagnostics and infrastructure. The company provides a comprehensive platform that includes access to a full clinical sandbox, open-source tools, and documentation, all designed to facilitate the translation of research into a secure and interoperable clinical environment. By offering these resources, Gradient Health aims to support developers in advancing medical imaging technologies and improving diagnostic processes using artificial intelligence.
Essenvia
Seed Round in 2023
Essenvia is an online software to streamline pre and post-market workflow for medical device companies by streamlining plans or activities to market, improving cross-functional collaboration, and automating steps to manage initial and subsequent device modifications.
TomBot
Seed Round in 2023
Tombot, Inc. is a company based in Valencia, California, that specializes in designing and developing robotic companion animals aimed at providing emotional support and companionship to children, adults, and seniors. Founded in 2017, Tombot's robotic pets are engineered to closely mimic the appearance and behaviors of real animals, featuring interactive capabilities such as touch sensitivity and voice recognition. The company's primary focus is on individuals with dementia or mild cognitive impairment, addressing issues like loneliness, anxiety, and depression through the use of robotic animals. Tombot aims to position its products not only as consumer wellness devices but also as FDA-approved medical devices capable of remote health monitoring. With significant equity funding and a growing customer base that includes hospitals and assisted living facilities, Tombot's innovative approach has garnered recognition, including a spot on TIME magazine's list of 100 Best Inventions in 2020. The company is set to begin beta testing in 2024, with its first shipments expected in 2025.
UptimeHealth
Series A in 2023
UptimeHealth, based in Boston, MA, is a software startup that specializes in equipment management for the healthcare sector. Its platform simplifies the management of medical device service events, purchases, and compliance through automation and predictive analytics. By offering user-friendly software, UptimeHealth enables administrators and operators to efficiently manage compliance tasks and access actionable data, thereby enhancing operational efficiencies. The company also connects users to a vast network of qualified biomedical technicians to support their medical devices. UptimeHealth's solutions aim to reduce costs and improve the quality of medical services by streamlining maintenance processes, automating documentation, and ensuring adherence to industry standards.
Advocatia
Series A in 2022
Advocatia Solutions, Inc. is a technology company based in Lake Bluff, Illinois, that specializes in benefit advocacy and enrollment software for hospitals and employers. Founded in 2016, Advocatia provides a suite of tools, including Benefit Screening, Benefit Text, and Benefit Triage, aimed at assisting uninsured and underinsured patients in navigating and securing available healthcare benefits. By partnering with hospitals, Advocatia helps reduce bad debt, optimize internal workflows, and create an audit trail for benefit enrollment, thereby facilitating access to healthcare options for patients post-discharge. The company's platform streamlines the financial assistance process, enabling healthcare organizations to efficiently engage and enroll patients in programs that enhance health outcomes while minimizing costs.
Skin Analytics
Series A in 2022
Skin Analytics is a technology company focused on improving skin health through innovative digital solutions. It develops a digital history of an individual's skin, enabling both users and healthcare professionals to measure, track, and understand skin changes over time. Utilizing patent-pending algorithms and artificial intelligence, the company analyzes smartphone images to identify and evaluate various skin conditions, including melanoma and precancerous lesions. By providing tools that empower individuals to manage their skin health proactively, Skin Analytics aims to enhance early detection and treatment options for skin cancer and other skin-related issues. The company plans to expand its range of skin health products over the next three years, catering to both consumer and clinical needs.
Ufonia
Seed Round in 2022
Ufonia is focused on transforming routine patient healthcare interactions by utilizing advanced AI-driven voice technology. The company develops automated phone calls that facilitate clinical follow-up, allowing healthcare organizations to efficiently capture patient-reported outcome measures. Through its conversational voice bot, Ufonia enables healthcare providers to monitor patient health and wellness more effectively, streamlining communication and enhancing the overall patient experience.
Carlsmed
Series B in 2022
Carlsmed is a medical technology company based in San Diego, California, founded in 2018. It specializes in developing innovative solutions for spine surgery, notably through its proprietary aprevo™ digital-to-device 3-D printed implant system. This system is recognized as the first surgical implant to receive FDA designation as a breakthrough technology, reflecting its potential to enhance patient outcomes. Carlsmed focuses on personalized medicine, particularly in lumbar fusion surgery, by utilizing machine learning and historical outcomes data to tailor treatments for complex adult spinal deformities. The company aims to improve surgical results while also reducing healthcare costs associated with spine surgery, making it a valuable partner for hospitals and surgeons nationwide.
Nest Collaborative
Seed Round in 2022
Nest Collaborative is a healthcare company that focuses on providing comprehensive lactation support through its online platform. It connects parents and parents-to-be with board-certified lactation consultants who offer virtual counseling services year-round. The company's approach emphasizes preventive care, aiming to improve access to lactation support and reduce associated costs. By employing evidence-based interventions, Nest Collaborative addresses the unique challenges many families face when breastfeeding, including physiological, emotional, societal, and economic barriers. Its services encompass breastfeeding education, prenatal planning, and practical tips for balancing motherhood, allowing mothers to access consultations without the need for co-pays. Through these offerings, Nest Collaborative seeks to extend the duration of breastfeeding and enhance the overall experience for families.
Camino Robotics
Seed Round in 2022
Camino Robotics produces and sells senior wellness products with features including an auto break, auto parking, auto lighting, and auto boosting. They sell their products online as well as offer home delivery services.
Gradient Health
Seed Round in 2022
Gradient Health is a developer of an open research platform that specializes in AI-based medical imaging diagnostics and infrastructure. The company provides a comprehensive platform that includes access to a full clinical sandbox, open-source tools, and documentation, all designed to facilitate the translation of research into a secure and interoperable clinical environment. By offering these resources, Gradient Health aims to support developers in advancing medical imaging technologies and improving diagnostic processes using artificial intelligence.
Epitel
Series A in 2022
Epitel is a digital health company focused on developing a wearable, wireless EEG monitoring platform aimed at enhancing seizure detection. The company's innovative device utilizes a proprietary cloud-based sensor system combined with advanced artificial intelligence technologies to accurately identify abnormal brain activities. By prioritizing accessibility, affordability, and reliability, Epitel enables physicians, caregivers, and patients with neurological disorders to obtain critical brain health insights, ultimately improving their quality of life and care.
Kiddo Health
Series A in 2022
Kiddo Health Inc offers a connected care platform tailored for children facing physical and behavioral health challenges. The platform is centered around a smart pediatric band designed for children aged three and above, which monitors vital signs including perspiration, activity levels, heart rate, and skin temperature. Accompanied by a companion app, Kiddo provides parents with actionable health insights, alerts, and recommendations to enhance the care of their children. Additionally, the platform facilitates care integrations such as telehealth services and doctor appointments in select markets, allowing healthcare providers to manage admission rates effectively and deliver proactive, cost-efficient care. Overall, Kiddo aims to improve the health and well-being of school-aged children and adolescents by integrating various health metrics to support both parents and healthcare professionals.
Sonic Incytes Medical
Series A in 2021
Sonic Incytes Medical Corp is a medical device company based in Vancouver, Canada, focused on developing handheld ultrasound solutions for the assessment and monitoring of chronic liver diseases. Incorporated in 2012, the company specializes in quantitative ultrasound technology that supports point-of-care diagnostics and procedure guidance. Its portable devices provide a non-invasive method for diagnosing liver diseases, particularly in quantifying fatty liver disease, thereby enhancing the standard of care provided by medical practitioners. The company's mission is to facilitate routine assessment and management of liver health with reliable diagnostic accuracy.
TripleBlind
Series A in 2021
TripleBlind, Inc. is a Kansas City-based company incorporated in 2019 that provides an online platform enabling organizations to collaborate while safeguarding sensitive data and algorithms. The company specializes in privacy-enhancing computation, offering a software-only solution delivered through a simple API. TripleBlind focuses on sectors such as healthcare and financial services, utilizing innovations like federated learning and multi-party computation to enhance the scalability and efficiency of privacy-preserving technology. Its platform allows institutions to share and monetize regulated data without compromising privacy, ensuring compliance with regulations like HIPAA and GDPR. By facilitating collaboration around sensitive data without decryption, TripleBlind enables clients to generate new revenue, derive deeper insights, and improve modeling and analysis. The company is supported by notable investors including Accenture, General Catalyst, and The Mayo Clinic, and it integrates seamlessly with major cloud platforms.
TomBot
Seed Round in 2021
Tombot, Inc. is a company based in Valencia, California, that specializes in designing and developing robotic companion animals aimed at providing emotional support and companionship to children, adults, and seniors. Founded in 2017, Tombot's robotic pets are engineered to closely mimic the appearance and behaviors of real animals, featuring interactive capabilities such as touch sensitivity and voice recognition. The company's primary focus is on individuals with dementia or mild cognitive impairment, addressing issues like loneliness, anxiety, and depression through the use of robotic animals. Tombot aims to position its products not only as consumer wellness devices but also as FDA-approved medical devices capable of remote health monitoring. With significant equity funding and a growing customer base that includes hospitals and assisted living facilities, Tombot's innovative approach has garnered recognition, including a spot on TIME magazine's list of 100 Best Inventions in 2020. The company is set to begin beta testing in 2024, with its first shipments expected in 2025.
Strados Labs
Seed Round in 2021
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.
Strados Labs
Series A in 2021
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.
DeepScribe
Seed Round in 2021
DeepScribe Inc is a company that specializes in artificial intelligence-powered medical scribing technology aimed at automating medical documentation for clinicians. Founded in 2017 and based in Berkeley, California, DeepScribe's platform utilizes advanced AI, machine learning, and natural language processing to capture and transcribe clinical conversations in real time. Its system extracts pertinent medical information and organizes it into comprehensive medical notes that seamlessly integrate with electronic health records. By providing a fully automated and user-friendly solution, DeepScribe alleviates the documentation burden on healthcare providers, allowing them to prioritize direct patient care. The company also offers robust integrations with a variety of popular EHR systems, enhancing its utility in clinical settings.
Materna Medical
Series A in 2021
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce maternal childbirth-related injuries during vaginal delivery. Established in 2010, the company addresses significant unmet needs in women's pelvic health, positioning itself within a $6 billion market. Materna Medical aims to transform the standard of care in obstetrics and gynecology by leveraging advanced technologies and a diverse team of engineers, scientists, and commercial leaders. The company’s mission is to empower women to safeguard their pelvic health through its novel medical devices.
Alertive Healthcare
Seed Round in 2021
Alertive Healthcare is a digital healthcare company focused on addressing the hypertension epidemic and managing chronic diseases. The company has developed a remote healthcare management platform that enables healthcare providers to monitor patients' blood pressure and other health metrics between doctor visits. Utilizing FDA-approved, Bluetooth-enabled blood pressure devices, Alertive Healthcare's platform collects and analyzes significant amounts of data, allowing care teams to communicate effectively and make timely clinical recommendations. This innovative approach significantly reduces the time required to achieve blood pressure control, potentially shortening it from the standard 18-24 months to as little as 10 weeks, thereby promoting better health outcomes for patients.
TripleBlind
Seed Round in 2021
TripleBlind, Inc. is a Kansas City-based company incorporated in 2019 that provides an online platform enabling organizations to collaborate while safeguarding sensitive data and algorithms. The company specializes in privacy-enhancing computation, offering a software-only solution delivered through a simple API. TripleBlind focuses on sectors such as healthcare and financial services, utilizing innovations like federated learning and multi-party computation to enhance the scalability and efficiency of privacy-preserving technology. Its platform allows institutions to share and monetize regulated data without compromising privacy, ensuring compliance with regulations like HIPAA and GDPR. By facilitating collaboration around sensitive data without decryption, TripleBlind enables clients to generate new revenue, derive deeper insights, and improve modeling and analysis. The company is supported by notable investors including Accenture, General Catalyst, and The Mayo Clinic, and it integrates seamlessly with major cloud platforms.
Nest Collaborative
Venture Round in 2021
Nest Collaborative is a healthcare company that focuses on providing comprehensive lactation support through its online platform. It connects parents and parents-to-be with board-certified lactation consultants who offer virtual counseling services year-round. The company's approach emphasizes preventive care, aiming to improve access to lactation support and reduce associated costs. By employing evidence-based interventions, Nest Collaborative addresses the unique challenges many families face when breastfeeding, including physiological, emotional, societal, and economic barriers. Its services encompass breastfeeding education, prenatal planning, and practical tips for balancing motherhood, allowing mothers to access consultations without the need for co-pays. Through these offerings, Nest Collaborative seeks to extend the duration of breastfeeding and enhance the overall experience for families.
Functional Fluidics
Seed Round in 2020
Functional Fluidics Inc. is a Detroit-based company founded in 2014 that specializes in developing biomarkers and surrogate endpoints to measure thrombosis and adhesion formation in whole blood, particularly for sickle cell disease. The company offers a range of proprietary blood function assays designed to standardize the assessment of red blood cell health and individual patient responses. Its services include flow adhesion, mechanical fragility, adhesion characterization, and adhesion avidity. Additionally, Functional Fluidics provides contract research services, which encompass initial consultation, preclinical validation, patient selection, monitoring, and the development of companion diagnostics. Through its innovative assays and research services, the company aims to enhance patient care by providing objective data on red blood cell health to pharmaceutical, biotech, and academic research organizations.
Carlsmed
Series A in 2020
Carlsmed is a medical technology company based in San Diego, California, founded in 2018. It specializes in developing innovative solutions for spine surgery, notably through its proprietary aprevo™ digital-to-device 3-D printed implant system. This system is recognized as the first surgical implant to receive FDA designation as a breakthrough technology, reflecting its potential to enhance patient outcomes. Carlsmed focuses on personalized medicine, particularly in lumbar fusion surgery, by utilizing machine learning and historical outcomes data to tailor treatments for complex adult spinal deformities. The company aims to improve surgical results while also reducing healthcare costs associated with spine surgery, making it a valuable partner for hospitals and surgeons nationwide.
Arcuity
Seed Round in 2020
Arcuity is a technology company specializing in document retrieval and review systems powered by artificial intelligence. The platform enhances efficiency and security in the retrieval and sharing of records, catering to litigants, claimants, and insurers. By leveraging advanced AI, Arcuity streamlines the process of creating complex reports, reduces duplicate records, and minimizes costs associated with document management. The system allows legal professionals to quickly read, index, and summarize large volumes of records, significantly increasing productivity and expediting claims review. Additionally, Arcuity's technology aids in uncovering critical information, thereby lowering risk for its users.
Hypercare
Seed Round in 2020
Patient care is becoming increasingly complex, requiring coordination and collaboration between multiple providers across different departments and specialties. However, hospitals and other healthcare settings have yet to catch up with these demands. The primary method of reaching providers is still through switchboards and pagers in hospitals. This ineffective modality leads to delays in patient care and poor patient outcomes. To take matters into their own hands, clinicians have resorted to non-secure smartphone apps such as WhatsApp and iMessage. However, this puts patient personal health information at risk, and creates enormous medico-legal liability for providers and hospitals.
Noteworth
Seed Round in 2020
Noteworth is a healthcare technology company founded in 2015 and based in Hoboken, New Jersey. It operates a patient data capture and delivery platform that connects healthcare organizations with patient-generated health data. The platform integrates over 400 FDA-approved clinical devices and delivers actionable data directly into existing electronic medical records. By providing software and services that enhance patient engagement, Noteworth allows clinicians to collect vital information and communicate effectively with patients through telemedicine and chat. The company's solutions aim to improve care delivery by reducing hospital readmissions, decreasing utilization, and enhancing overall patient satisfaction, thereby fostering a collaborative relationship between patients and healthcare providers.
Carlsmed
Seed Round in 2020
Carlsmed is a medical technology company based in San Diego, California, founded in 2018. It specializes in developing innovative solutions for spine surgery, notably through its proprietary aprevo™ digital-to-device 3-D printed implant system. This system is recognized as the first surgical implant to receive FDA designation as a breakthrough technology, reflecting its potential to enhance patient outcomes. Carlsmed focuses on personalized medicine, particularly in lumbar fusion surgery, by utilizing machine learning and historical outcomes data to tailor treatments for complex adult spinal deformities. The company aims to improve surgical results while also reducing healthcare costs associated with spine surgery, making it a valuable partner for hospitals and surgeons nationwide.
TomBot
Seed Round in 2020
Tombot, Inc. is a company based in Valencia, California, that specializes in designing and developing robotic companion animals aimed at providing emotional support and companionship to children, adults, and seniors. Founded in 2017, Tombot's robotic pets are engineered to closely mimic the appearance and behaviors of real animals, featuring interactive capabilities such as touch sensitivity and voice recognition. The company's primary focus is on individuals with dementia or mild cognitive impairment, addressing issues like loneliness, anxiety, and depression through the use of robotic animals. Tombot aims to position its products not only as consumer wellness devices but also as FDA-approved medical devices capable of remote health monitoring. With significant equity funding and a growing customer base that includes hospitals and assisted living facilities, Tombot's innovative approach has garnered recognition, including a spot on TIME magazine's list of 100 Best Inventions in 2020. The company is set to begin beta testing in 2024, with its first shipments expected in 2025.
Cellsonics
Venture Round in 2020
Cellsonics is setting new standards with single-cell sample preparation, delivering the individual characteristics of each patient sample for a precision medicine approach to the analysis, treatment, and diagnosis of disease. The company develops products to suit any lab processing solid tissue samples for single cell analysis, cancer tumor profiling, and primary tissue culture.
Meenta
Seed Round in 2020
Meenta, Inc. is a Boston-based company founded in 2016, specializing in a cloud-based platform that facilitates the booking and management of gene sequencing services for scientists. The platform addresses the fragmented life sciences outsourcing market by allowing researchers to efficiently find, book, and send samples to various host sites equipped for gene sequencing. By connecting scientists with a network of service providers, Meenta aims to enhance accessibility to scientific equipment and clinical tests, thereby streamlining the research process. The company's innovative approach supports research scientists in their quest for efficient and effective laboratory solutions.
Materna Medical
Seed Round in 2020
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce maternal childbirth-related injuries during vaginal delivery. Established in 2010, the company addresses significant unmet needs in women's pelvic health, positioning itself within a $6 billion market. Materna Medical aims to transform the standard of care in obstetrics and gynecology by leveraging advanced technologies and a diverse team of engineers, scientists, and commercial leaders. The company’s mission is to empower women to safeguard their pelvic health through its novel medical devices.
MedPilot
Series A in 2020
MedPilot Inc. is a Cleveland-based company that offers an AI-driven patient relationship management platform, established in 2014. The company specializes in addressing administrative and billing challenges within the healthcare sector. MedPilot provides a payment platform that simplifies the verification process for patients, clearly explaining their financial obligations. Additionally, it enhances the patient experience through post-payment surveys that gather valuable feedback for healthcare providers. The platform includes a network of patient navigators who assist in managing medical payments, offering billing discounts and customizable payment plans. By focusing on advocacy services, MedPilot aims to resolve payment issues and optimize the overall patient experience in the healthcare community.
FastDetect
Seed Round in 2020
FastDetect develops diagnostic equipment designed for testing COVID-19. Its testing systems are designed for testing multiple people simultaneously, providing the test results within minutes and allowing people to swiftly determine whether they are infected. The company was founded in 2020 and is headquartered in Pasadena, California.
Matterworks
Seed Round in 2020
Matterworks is a biotech startup that combines metabolomics with AI to simulate the metabolic environment. The startup is enabling real-time insights into cellular biology to accelerate therapeutic research, development, and manufacturing with an AI-driven cloud platform for metabolomics. Matterworks was founded by Mimoun Cadosch Delmar and Jack Geremia in 2019.
Iterative Scopes
Series A in 2019
Iterative Scopes, Inc. is a Boston-based company established in 2017 that specializes in developing machine learning-powered diagnostic tools aimed at assisting gastroenterologists in the prevention of colon cancer. The company focuses on providing innovative solutions for physicians and life sciences professionals within the colorectal cancer and inflammatory bowel disease sectors. By leveraging advanced technology, Iterative Scopes aims to enhance diagnostic accuracy and improve patient outcomes in these critical areas of healthcare.
MedPilot
Seed Round in 2019
MedPilot Inc. is a Cleveland-based company that offers an AI-driven patient relationship management platform, established in 2014. The company specializes in addressing administrative and billing challenges within the healthcare sector. MedPilot provides a payment platform that simplifies the verification process for patients, clearly explaining their financial obligations. Additionally, it enhances the patient experience through post-payment surveys that gather valuable feedback for healthcare providers. The platform includes a network of patient navigators who assist in managing medical payments, offering billing discounts and customizable payment plans. By focusing on advocacy services, MedPilot aims to resolve payment issues and optimize the overall patient experience in the healthcare community.
DeepScribe
Seed Round in 2019
DeepScribe Inc is a company that specializes in artificial intelligence-powered medical scribing technology aimed at automating medical documentation for clinicians. Founded in 2017 and based in Berkeley, California, DeepScribe's platform utilizes advanced AI, machine learning, and natural language processing to capture and transcribe clinical conversations in real time. Its system extracts pertinent medical information and organizes it into comprehensive medical notes that seamlessly integrate with electronic health records. By providing a fully automated and user-friendly solution, DeepScribe alleviates the documentation burden on healthcare providers, allowing them to prioritize direct patient care. The company also offers robust integrations with a variety of popular EHR systems, enhancing its utility in clinical settings.
UptimeHealth
Seed Round in 2019
UptimeHealth, based in Boston, MA, is a software startup that specializes in equipment management for the healthcare sector. Its platform simplifies the management of medical device service events, purchases, and compliance through automation and predictive analytics. By offering user-friendly software, UptimeHealth enables administrators and operators to efficiently manage compliance tasks and access actionable data, thereby enhancing operational efficiencies. The company also connects users to a vast network of qualified biomedical technicians to support their medical devices. UptimeHealth's solutions aim to reduce costs and improve the quality of medical services by streamlining maintenance processes, automating documentation, and ensuring adherence to industry standards.
Ready, Set, Food!
Pre Seed Round in 2019
Ready, Set, Food! is a California-based company founded in 2017 that specializes in manufacturing and selling food products designed for infants. The company's main goal is to help parents reduce the risk of their babies developing allergies to common foods such as peanuts, eggs, and milk. Ready, Set, Food! offers a gentle, daily system that simplifies the introduction of these allergenic foods into infants' diets, potentially lowering the risk of allergies by up to 80%. The products are available for purchase online, making them accessible to a wide range of consumers.
Luna
Seed Round in 2019
Physical therapy is powerful—for developing strength, managing emerging conditions, or recovering from surgery. But it’s challenging for physical therapy to make a significant clinical impact because therapists and patients are worn out. Traditional physical therapy leaves more than 50% of therapists suffering from work-related pain and 70% of patients failing to complete their course of care. On both sides of the therapy table, people need better support. At Luna, they’re designing a practice that gives therapists and patients the independence, control, and motivation they need to feel meaningful relief.
Visual Health Solutions
Seed Round in 2019
Visual Health Solutions is a company focused on enhancing patient understanding and engagement through the creation of multimedia content, including 3D medical animations, medical illustrations, and interactive graphics. By leveraging advanced technology and specialized knowledge, the company produces educational training programs that address complex medical conditions and challenges. Their work serves a diverse audience, including healthcare providers, clinical professionals, patients, and entities in the pharmaceutical and medical device sectors. Through a collaborative approach, Visual Health Solutions effectively communicates intricate health information, enabling patients to comprehend treatment plans and make informed health decisions.
Cellsonics
Seed Round in 2019
Cellsonics is setting new standards with single-cell sample preparation, delivering the individual characteristics of each patient sample for a precision medicine approach to the analysis, treatment, and diagnosis of disease. The company develops products to suit any lab processing solid tissue samples for single cell analysis, cancer tumor profiling, and primary tissue culture.
xCures
Seed Round in 2019
xCures, Inc. is a healthcare technology company founded in 2018 and based in Los Altos, California, focused on transforming cancer treatment through its innovative AI-based precision oncology platform. The company addresses the challenges of traditional drug-centric treatment development by integrating cancer research and patient care. Its platform operates as a perpetual trial, continuously capturing Real World Evidence (RWE) from patients and treatments, allowing for real-time learning and adaptation. By coordinating treatment recommendations across various institutions, xCures ensures that patients receive personalized treatment options tailored to their specific needs. Additionally, the platform organizes insights from tumor boards, leveraging machine learning to assist healthcare professionals in making informed decisions. This approach not only enhances the effectiveness of cancer care but also aims to reduce the time and cost associated with drug development, ultimately improving patient outcomes.
Medaptive Health
Seed Round in 2019
Medaptive Health is a developer of patient engagement technology aimed at transforming the operation of clinical trials. The company offers an open-source solution that leverages platforms such as CareKit, ResearchKit, and ResearchStack to create health offerings. Medaptive Health's technology automates engagement, providing personalized support to large populations while delivering insights through built-in analytics. This approach addresses common challenges in clinical research, helping organizations to save time and resources and enhance the efficiency of clinical trials.
Advekit
Pre Seed Round in 2019
Advekit, LLC is a healthcare technology company based in Venice, California, that operates an online platform designed to streamline the process of connecting patients with mental health professionals. Founded in 2017, Advekit utilizes users' zip codes, preferences, and insurance information to facilitate tailored matches with therapists. The platform aims to make mental health support more accessible and user-friendly by allowing patients to navigate their mental health benefits effectively. Additionally, Advekit offers a sliding-scale fee structure to accommodate varying financial situations, ensuring that users can find appropriate support that aligns with their needs, availability, and insurance coverage.
Regard
Seed Round in 2019
Regard is a healthcare technology company that offers an intelligent platform aimed at enhancing hospital operations and patient care. Utilizing artificial intelligence, the platform analyzes medical records to extract relevant information, assist in diagnosing critical conditions, and generate accurate documentation. This approach not only streamlines administrative processes but also improves hospital finances, patient safety, and physician satisfaction. By minimizing coding queries and reducing the burden of administrative tasks, Regard enables healthcare professionals to focus more on patient care while optimizing reimbursement processes. The company's solutions cater to various stakeholders within the healthcare system, ultimately contributing to a more efficient and effective healthcare environment.
Giblib
Seed Round in 2019
Giblib is a California-based company founded in 2015 and headquartered in Los Angeles. It operates an online video community platform that serves as a resource for medical education, akin to a streaming service for surgical knowledge. The platform allows surgeons to share and access a curated collection of surgical videos and medical lectures across various specialties. By indexing surgical procedures and creating educational content, Giblib provides medical students and practitioners with valuable insights into surgical techniques and medical practices from experienced professionals.
Evid Science
Seed Round in 2019
Evid Science is a technology company that develops an advanced platform designed for life science companies, utilizing artificial intelligence and machine learning to analyze primary medical literature. Its AI-driven system provides a comprehensive and up-to-date database of therapy evidence, allowing users to efficiently track and find relevant data from peer-reviewed articles on pharmaceuticals and clinical research. By streamlining the evidence synthesis process, Evid Science's platform accelerates workflows involved in literature search, screening, analysis, and content creation. This innovative approach enables data-driven decision-making and enhances clinical support, ultimately facilitating real-time access to crucial medical evidence.
Luminate Health
Seed Round in 2019
Luminate Health, Inc. provides a HIPAA-compliant, SaaS solution to labs and healthcare providers, which enables patients to access, manage, and understand their lab results. The company was founded in 2013 and is based in San Mateo, California.
Third Eye Health
Series A in 2019
Third Eye Health, Inc. is a healthcare company based in Chicago, Illinois, that specializes in telehealth services for post-acute and senior care organizations. Established in 2014, the company operates an online platform that enables healthcare providers to exchange medical information and conduct real-time telemedicine using wearable technology. Its primary solution, EmergencyAssist, supports emergency medical technicians and healthcare workers by facilitating detailed triage and the transmission of critical information to hospital emergency departments and specialists through real-time video and data sharing. Additionally, Third Eye Health aims to reduce avoidable hospital readmissions by providing immediate care and consultations, ensuring that patients receive timely attention in various settings, including emergency vehicles and their homes.
Savonix
Series A in 2018
Savonix, Inc. is a company that develops an evidence-based digital neuro-cognitive assessment platform aimed at enhancing brain health. Its flagship product, Savonix Mobile, allows users to conduct clinically recognized cognitive assessments directly on their mobile devices. This platform serves a diverse clientele, including healthcare providers, researchers, and large corporations, enabling them to evaluate cognitive function in various domains such as memory and cognitive flexibility. The assessments are guided and reported by a virtual clinician, facilitating the understanding of risks associated with dementia and other brain disorders. Notably, Savonix incorporates a unique 3D game platform that derives insights into cognitive functions, such as Implicit Learning, from user interactions within the app. Founded in 2014 and based in San Francisco, Savonix has established strategic partnerships with institutions like New York University and several biotechnology firms to enhance its offerings and impact in the field of cognitive health.
SeqOnce Biosciences
Seed Round in 2018
SeqOnce Biosciences is a biotechnology company established in 2014, emerging from the University of Southern California. It focuses on accelerating discoveries in life sciences to enhance the human condition, encompassing applications such as pathogen detection and disease-related biomarker identification. The company specializes in developing genomic sequencing preparation kits aimed at qualitative multi-plex in-vitro assessment of various microbiota, particularly those related to sexually transmitted infections. Utilizing advanced techniques like real-time PCR and next-generation sequencing, SeqOnce aims to deliver faster and more accurate results through innovative technologies. With a team led by experts in molecular biology, technology development, finance, and operations, SeqOnce is rapidly expanding its portfolio across genomics, food safety, and pathogen detection, striving to provide cost-effective solutions for clinical researchers.
Rosalind
Seed Round in 2018
The usual process of learning bioinformatics requires the solution of computational problems of varying difficulty that are extracted from real challenges of molecular biology. In an attempt to make the experience of learning bioinformatics as effective and enjoyable as possible, we have founded Rosalind, a programming and testing platform for bioinformatics problems. The Rosalind website checks solutions to these problems automatically and provides students of all abilities with an intellectually stimulating way to learn key bioinformatics concepts and algorithms online at their own pace and independent of students' access to university resources. Rosalind also promises to facilitate improvements in standard undergraduate bioinformatics education by providing a vital teaching aid. Rosalind is inspired by Project Euler, Google Code Jam, and free online courses. The project's name commemorates Rosalind Franklin, whose X-ray crystallography facilitated the discovery of the double helix by Watson and Crick.
Joany
Seed Round in 2018
JOANY Inc., operating as JOANY Health Insurance Services, is an online insurance brokerage based in Los Angeles, California. Established in 2016 and rebranded from Impact Health in 2017, JOANY provides a range of services designed to streamline the process of buying and managing health insurance. The company utilizes machine learning and a comprehensive database to analyze individual consumer needs, helping clients select suitable insurance plans efficiently. In addition to insurance brokerage, JOANY offers services such as doctor matching, billing counsel, and healthcare navigation, positioning itself as a healthcare concierge to simplify the complexities of health insurance throughout the year.
Trusted Health
Seed Round in 2018
Trusted, Inc. operates a digital employment platform specifically designed for nurses, streamlining the recruitment process for healthcare institutions. Founded in 2017 and headquartered in San Francisco, the company provides a fully automated online employment agency that connects nurses with flexible job opportunities tailored to their preferences and career goals. The platform digitizes and manages essential documents such as resumes, credentials, and certifications, allowing candidates to explore new opportunities efficiently. Additionally, Trusted's flagship staffing platform, Trusted Works, addresses the challenges hospitals face in filling shifts by enabling facilities to create an on-demand nursing workforce. It offers predictive insights and recommendations, helping hospitals adapt to fluctuations in demand while maintaining compliance. This innovative approach not only enhances the recruitment process but also fosters competition among a network of pre-onboarded talent suppliers, ensuring access to high-quality nursing professionals.
Kiddo Health
Venture Round in 2018
Kiddo Health Inc offers a connected care platform tailored for children facing physical and behavioral health challenges. The platform is centered around a smart pediatric band designed for children aged three and above, which monitors vital signs including perspiration, activity levels, heart rate, and skin temperature. Accompanied by a companion app, Kiddo provides parents with actionable health insights, alerts, and recommendations to enhance the care of their children. Additionally, the platform facilitates care integrations such as telehealth services and doctor appointments in select markets, allowing healthcare providers to manage admission rates effectively and deliver proactive, cost-efficient care. Overall, Kiddo aims to improve the health and well-being of school-aged children and adolescents by integrating various health metrics to support both parents and healthcare professionals.
Good Parent
Seed Round in 2018
Good Parent, Inc., is a corporation established in 2010 to provide scientific research, education, and entertainment to parents, children and educators.
Ciitizen
Venture Round in 2018
Ciitizen Corporation is a healthcare technology company based in Palo Alto, California, that operates a digital platform designed to empower patients to collect, organize, and share their personal health information, including genomic data and lab results. Founded in 2017, Ciitizen aims to give individuals control over their complete health records, facilitating the sharing of this information with caregivers, researchers, and other relevant parties. The platform addresses the limitations of existing health data portals, which often provide only minimal information and rely on labor-intensive processes to extract insights from unstructured data. By normalizing diverse health information into actionable formats, Ciitizen enhances transparency and accessibility for patients and healthcare providers alike. The company is led by CEO Anil Sethi and is supported by a prominent investment team.
Nicolette
Pre Seed Round in 2018
Nicolette, Inc. is a healthcare technology company that focuses on empowering parents of infants in the Neonatal Intensive Care Unit (NICU) through its innovative dashboard application. This application provides a comprehensive visual, audio, and interactive display of a baby's health data and diagnosis, allowing users to track progress and understand care plans effectively. The platform also offers access to electronic medical records, curated research, a directory of healthcare professionals, remote communication with physicians, and a personal notes diary, enhancing collaboration between parents and medical teams. Founded in 2016 and based in Corte Madera, California, Nicolette aims to enable parents to become informed advocates for their children's health.
Precise TeleHealth
Seed Round in 2018
Precise TeleHealth is a provider of telemedical services focused on addressing the healthcare needs of patients with complex medical and behavioral conditions, particularly in rural and underserved areas. The company utilizes a platform designed to enhance healthcare delivery by optimizing communication and collaboration between healthcare providers and patients. By offering face-to-face telemedicine and value-based Chronic Care Management services, Precise TeleHealth aims to reduce the costs associated with multiple chronic diseases while ensuring a higher quality of care. Their approach helps healthcare professionals deliver improved treatment and achieve better clinical outcomes for patients.
Meenta
Seed Round in 2018
Meenta, Inc. is a Boston-based company founded in 2016, specializing in a cloud-based platform that facilitates the booking and management of gene sequencing services for scientists. The platform addresses the fragmented life sciences outsourcing market by allowing researchers to efficiently find, book, and send samples to various host sites equipped for gene sequencing. By connecting scientists with a network of service providers, Meenta aims to enhance accessibility to scientific equipment and clinical tests, thereby streamlining the research process. The company's innovative approach supports research scientists in their quest for efficient and effective laboratory solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.